Researchers at McGill’s Centre of Genomics and Policy (CGP) have launched a first-of-its-kind guide to help Canadian health-care providers offer more inclusive, respectful and affirming care to intersex adults.

McGill University researchers have developed an artificial intelligence tool that can detect previously invisible disease markers inside single cells.

In a study published in Nature Communications, the researchers demonstrate how the tool, called DOLPHIN, could one day be used by doctors to catch diseases earlier and guide treatment options.

Jérôme Fortin, Paul Masset, and Simon Thebault have received the Future Leaders in Canadian Brain Research Award from Brain Canada for their research in brain cognition, brain cancer, and neurological disabilities.  

The McGill researchers are among 22 successful applicants from across the country. They will each receive $100,000 in research funding distributed over a period of two years. 

A surgical device powered by artificial intelligence (AI) was demonstrated live for the first time at The Neuro (Montreal Neurological Institute-Hospital) in a historic step forward for the field of precision neurosurgery. SENTRY™, an innovative technology developed by Montreal-based Reveal and its university partners, can differentiate cancerous tissue from healthy tissue in real time, offering tangible hope to patients for better outcomes.

A surgical device powered by artificial intelligence (AI) was demonstrated live for the first time at The Neuro (Montreal Neurological Institute-Hospital) in a historic step forward for the field of precision neurosurgery. SENTRY™, an innovative technology developed by Montreal-based Reveal and its university partners, can differentiate cancerous tissue from healthy tissue in real time, offering tangible hope to patients for better outcomes.

A surgical device powered by artificial intelligence (AI) was demonstrated live for the first time at The Neuro (Montreal Neurological Institute-Hospital) in a historic step forward for the field of precision neurosurgery. SENTRY™, an innovative technology developed by Montreal-based Reveal and its university partners, can differentiate cancerous tissue from healthy tissue in real time, offering tangible hope to patients for better outcomes.

A groundbreaking project led by Dr. Pedro Rosa-Neto at The Neuro (Montreal Neurological Institute-Hospital) of McGill University has received a major boost thanks to a $10-million grant from the Weston Family Foundation.

The funding is part of a $20-million initiative by the foundation to support highly ambitious scientific endeavors under its Healthy Aging Strategy, comprised of the Weston Brain Institute and the Weston Family Microbiome Initiative.

A groundbreaking project led by Dr. Pedro Rosa-Neto at The Neuro (Montreal Neurological Institute-Hospital) of McGill University has received a major boost thanks to a $10-million grant from the Weston Family Foundation.

The funding is part of a $20-million initiative by the foundation to support highly ambitious scientific endeavors under its Healthy Aging Strategy, comprised of the Weston Brain Institute and the Weston Family Microbiome Initiative.

A groundbreaking project led by Dr. Pedro Rosa-Neto at The Neuro (Montreal Neurological Institute-Hospital) of McGill University has received a major boost thanks to a $10-million grant from the Weston Family Foundation.

The funding is part of a $20-million initiative by the foundation to support highly ambitious scientific endeavors under its Healthy Aging Strategy, comprised of the Weston Brain Institute and the Weston Family Microbiome Initiative.

A groundbreaking project led by Dr. Pedro Rosa-Neto at The Neuro (Montreal Neurological Institute-Hospital) of McGill University has received a major boost thanks to a $10-million grant from the Weston Family Foundation.

The funding is part of a $20-million initiative by the foundation to support highly ambitious scientific endeavors under its Healthy Aging Strategy, comprised of the Weston Brain Institute and the Weston Family Microbiome Initiative.

Access to respite services for family caregivers increases a palliative care patient’s probability of dying at home almost threefold, according to a McGill University-led study.

Previous surveys suggest most Canadians with a serious illness would prefer to spend the end of their lives at home. In Quebec, fewer than one-in-10 palliative care patients die at home, a rate that has remained largely unchanged for two decades and lags behind the Canadian average of 15 per cent.

Access to respite services for family caregivers increases a palliative care patient’s probability of dying at home almost threefold, according to a McGill University-led study.

Previous surveys suggest most Canadians with a serious illness would prefer to spend the end of their lives at home. In Quebec, fewer than one-in-10 palliative care patients die at home, a rate that has remained largely unchanged for two decades and lags behind the Canadian average of 15 per cent.

Access to respite services for family caregivers increases a palliative care patient’s probability of dying at home almost threefold, according to a McGill University-led study.

Previous surveys suggest most Canadians with a serious illness would prefer to spend the end of their lives at home. In Quebec, fewer than one-in-10 palliative care patients die at home, a rate that has remained largely unchanged for two decades and lags behind the Canadian average of 15 per cent.

Access to respite services for family caregivers increases a palliative care patient’s probability of dying at home almost threefold, according to a McGill University-led study.

Previous surveys suggest most Canadians with a serious illness would prefer to spend the end of their lives at home. In Quebec, fewer than one-in-10 palliative care patients die at home, a rate that has remained largely unchanged for two decades and lags behind the Canadian average of 15 per cent.

We take our understanding of where we are for granted, until we lose it. When we get lost in nature or a new city, our eyes and brains kick into gear, seeking familiar objects that tell us where we are.

How our brains distinguish objects from background when finding direction, however, was largely a mystery. A new study provides valuable insight into this process, with possible implications for disorientation-causing conditions such as Alzheimer’s.

We take our understanding of where we are for granted, until we lose it. When we get lost in nature or a new city, our eyes and brains kick into gear, seeking familiar objects that tell us where we are.

How our brains distinguish objects from background when finding direction, however, was largely a mystery. A new study provides valuable insight into this process, with possible implications for disorientation-causing conditions such as Alzheimer’s.

We take our understanding of where we are for granted, until we lose it. When we get lost in nature or a new city, our eyes and brains kick into gear, seeking familiar objects that tell us where we are.

How our brains distinguish objects from background when finding direction, however, was largely a mystery. A new study provides valuable insight into this process, with possible implications for disorientation-causing conditions such as Alzheimer’s.

We take our understanding of where we are for granted, until we lose it. When we get lost in nature or a new city, our eyes and brains kick into gear, seeking familiar objects that tell us where we are.

How our brains distinguish objects from background when finding direction, however, was largely a mystery. A new study provides valuable insight into this process, with possible implications for disorientation-causing conditions such as Alzheimer’s.

We take our understanding of where we are for granted, until we lose it. When we get lost in nature or a new city, our eyes and brains kick into gear, seeking familiar objects that tell us where we are.

How our brains distinguish objects from background when finding direction, however, was largely a mystery. A new study provides valuable insight into this process, with possible implications for disorientation-causing conditions such as Alzheimer’s.